Philadelphia, March 30, 1999 -- Cancer researchers from around the world will meet in April at the 90th Annual Meeting of American Association for Cancer Research (AACR) to share cutting-edge research findings in the rapidly advancing areas of translational research and molecular genetics, including anti-angiogenesis agents, cancer vaccines, gene therapy, and molecular targeted therapy. The meeting will take place from April 10-14 at the Pennsylvania Convention Center in Philadelphia, and will feature close to 5,000 abstracts and 200 invited presentations. Two special late-breaking research sessions will offer reports of highly significant and timely findings that have occurred within the last few months. A new feature at the Annual Meeting is a special lecture, given this year by Nobel Laureate James D. Watson, Ph.D., entitled "From the Double Helix to DNA Tumor Viruses."
"As the pace of scientific discovery accelerates, it is essential to present the most up-to-date and novel information to the scientific community and the public in order to make progress against cancer," said Webster K. Cavenee Ph.D., President of AACR and Director, Ludwig Institute for Cancer Research in La Jolla, CA. "To that end, we have been closely monitoring scientific developments and will present research on the latest research findings in all of the subdisciplines of cancer research."
"For the last five months, the 90th Annual Meeting Program Committee has been
working to examine the entire field of cancer research and identify the most
rapidly developing research areas, as well as the most appropriate scientists
to organize the sessions in which these new data will be presented," said Waun
Ki Hong, M.D., American Cancer Society Clinical Research Professor, Professor
and Chairman, Department of Thoracic/Head and Neck Oncology, UT M.D. Anderson
Cancer Center, Charles A. LeMaistre Distinguished Chair in Thoracic Oncology,
Chairperson of the AACR Program C
Contact: Jack Cooley
Cooney Waters Group, Inc.